Precision medicine is a rapidly growing approach to health care that focuses on finding treatments and interventions that work for people based on their genetic makeup, rather than their symptoms. Zeeshan Ahmed, director of the new Ahmed Lab at Rutgers Institute for Health, Health Care Policy and Aging Research, discusses the future of precision medicine, what needs to be done to successfully analyze the data necessary to develop individualized treatments and the role genetics play during the COVID-19 pandemic. To read the full story.
Recent Posts
- NIH Fellowship Writing Group: Call for Applications – Sign Up by 8/25
- Join The National Clinical Cohort Collaborative (N3C) Community Forum on 7/30
- NIH Fellowship Writing Group: Call for Applications – Sign Up by 8/25
- Rutgers Students Showcase AI-Driven Research Success Through NJ ACTS Summer Research Program
- Rutgers NJHealth Study Data Access Opportunity – Application Due July 6th!
Categories
- Community (2,500)
- Covid (1,001)
- CTO Events (6)
- News (3,174)
- Pilots (21)